These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 805052)

  • 1. Effect of ICI 66082, a beta-adrenoceptor blocking drug on blood glucose in the rat.
    Furman BL; Tayo FM
    Eur J Pharmacol; 1975 Mar; 31(1):115-21. PubMed ID: 805052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of alpha- and beta-adrenoceptor subtypes in mediating the effects of catecholamines on fasting glucose and insulin concentrations in the rat.
    John GW; Doxey JC; Walter DS; Reid JL
    Br J Pharmacol; 1990 Aug; 100(4):699-704. PubMed ID: 1976400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of the beta 3-adrenoceptor agonist, BRL 35135, on tissue glucose utilisation.
    Liu YL; Stock MJ
    Br J Pharmacol; 1995 Feb; 114(4):888-94. PubMed ID: 7773551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Pringle TH; O'Connor PC; McNeill AJ; Finch MB; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1986 Mar; 21(3):249-58. PubMed ID: 2870732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.
    Liu YL; Cawthorne MA; Stock MJ
    Br J Pharmacol; 1996 Mar; 117(6):1355-61. PubMed ID: 8882636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: The hypoglycaemic action of ICI 66082 (4-(2-hydroxy-3-isopropyl-aminopropoxy) phenyl acetamide) in the rat.
    Furman BL; Tayo FM
    Br J Pharmacol; 1974 Sep; 52(1):143P. PubMed ID: 4155984
    [No Abstract]   [Full Text] [Related]  

  • 7. Human pharmacokinetic and pharmacodynamic studies on the atenolo (ICI 66,082), a new cardioselective beta-adrenoceptor blocking drug.
    Conway FJ; Fitzgerald JD; McAinsh J; Rowlands DJ; Simpson WT
    Br J Clin Pharmacol; 1976 Apr; 3(2):267-72. PubMed ID: 973955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta 1- and beta 2-adrenoceptor antagonist activities of ICI-215001, a putative beta 3-adrenoceptor agonist.
    Tesfamariam B; Allen GT
    Br J Pharmacol; 1994 May; 112(1):55-8. PubMed ID: 7913381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of ICI 66082, a new beta-adrenoceptor blocking drug, on the submaxillary gland of the rat.
    Gjörstrup P
    Experientia; 1975 May; 31(5):550. PubMed ID: 1140251
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of the beta 2-adrenoceptor antagonist ICI 118,551 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.
    Arnold JM; O'Connor PC; Riddell JG; Harron DW; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1985 May; 19(5):619-30. PubMed ID: 2860915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective stimulation of glucagon secretion by beta 2-adrenoceptors in isolated islets of Langerhans of the rat.
    Lacey RJ; Berrow NS; Scarpello JH; Morgan NG
    Br J Pharmacol; 1991 Jul; 103(3):1824-8. PubMed ID: 1718526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glyburide in a rat model of reduced B-cell mass.
    Leahy JL; Samols MD; Weir GC
    Prog Clin Biol Res; 1988; 265():87-98. PubMed ID: 3136456
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of selective (beta-1 and beta-2) and nonselective beta adrenoceptor antagonists on the cardiovascular and metabolic responses to isoproterenol: comparison with ICI 141,292.
    Smith HJ; Halliday SE; Earl DC; Stribling D
    J Pharmacol Exp Ther; 1983 Jul; 226(1):211-6. PubMed ID: 6134820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta1 and beta2 adrenoceptors in isoproterenol-induced drinking.
    Kirby RF; Novak CM; Thunhorst RL; Johnson AK
    Brain Res; 1994 Sep; 656(1):79-84. PubMed ID: 7804848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of adrenodemedullation on beta 2- and beta 3-adrenoceptors mediating relaxation of oesophageal smooth muscle of spontaneously hypertensive rats.
    de Boer RE; Steegstra MR; Kroezen PA; Smit J; Zaagsma J
    Br J Pharmacol; 1996 Dec; 119(7):1355-60. PubMed ID: 8968543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.
    Nathanson JA
    Br J Pharmacol; 1984 Nov; 83(3):821-9. PubMed ID: 6150744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The assessment of the beta-adrenoceptor blocking activity and cardioselectivity of Koe 3290 in normal subjects.
    Pringle TH; McNeill AJ; Riddell JG; Shanks RG
    Br J Clin Pharmacol; 1987 Nov; 24(5):581-9. PubMed ID: 2893635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hypoglycaemic effect of 5-hydroxytryptophan.
    Furman BL
    Br J Pharmacol; 1974 Apr; 50(4):575-80. PubMed ID: 4548658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenaline, beta-adrenoceptor mediated vasorelaxation and nitric oxide in large and small pulmonary arteries of the rat.
    Priest RM; Hucks D; Ward JP
    Br J Pharmacol; 1997 Dec; 122(7):1375-84. PubMed ID: 9421285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists.
    McGibney D; Singleton W; Silke B; Taylor SH
    Br J Clin Pharmacol; 1983 Jan; 15(1):15-9. PubMed ID: 6849739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.